10.50
10.50 (0%)
As of Feb 14, 2025
Lensar, Inc. [LNSR]
Source:
Company Overview
Lensar, Inc is a commercial-stage medical device company focused on designing, developing and marketing advanced laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism.
| Country | United States |
| Headquarters | orlando, florida |
| Phone Number | (888) 536-7271 |
| Industry | manufacturing |
| CEO | Nicholas T. Curtis |
| Website | www.lensar.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $53.5 |
| Operating Profit | $-10.7 |
| Net Income | $-31.4 |
| Net Cash | $-4.4 |
Profit Ratios
| Gross Margin | $25.9 |
| Operating Margin | -19.9 |
| Profit as % of Revenues | -82.3% |
| Profit as % of Assets | -46.2% |
| Profit as % of Stockholder Equity | -645.9% |
Management Effectiveness
| Return on Equity | -645.9% |
| Return on Assets | -47.4% |
| Turnover Ratio | 78.7% |
| EBITA | $-9.7 |
Balance Sheet and Cash Flow Measures
| Total Assets | $66.3 |
| Total Liabilities | $47.7 |
| Operating Cash Flow | $-2.3 |
| Investing Cash Flow | $-2.2 |
| Financing Cash Flow | $0.1 |
